Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical features, genotypes, and geographic distribution of 238 Latin American CGD patients.

Journal of human immunity·2026
Same author

Human Plasma-Derived C1 Inhibitor for Short-Term Prophylaxis in Hereditary Angioedema With Normal C1 Inhibitor.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Family quality-of-life burden in chronic spontaneous urticaria: A multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Real-World Evidence on the Management of Hereditary Angioedema With Normal C1 Inhibitor.

The journal of allergy and clinical immunology. In practice·2025
Same author

Evaluating functional C1INH with multiple laboratory methods across Hereditary Angioedema types.

Frontiers in immunology·2025
Same author

Mucosal angioedema involving the oropharynx signals severe cold urticaria: COLD-CE study insights.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025

Related Experiment Video

Updated: Jun 15, 2026

Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats
13:26

Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats

Published on: July 19, 2007

[Delayed pressure urticaria with systemic manifestations: Case report].

Sérgio Duarte Dortas1, Solange Oliveira Rodrigues Valle, Andréa Huguenim Silva Pires

  • 1Universidade Federal do Rio de Janeiro, RJ, Brasil. sdortasjr@gmail.com

Anais Brasileiros De Dermatologia
|March 2, 2010
PubMed
Summary

Delayed Pressure Urticaria is a rare condition often misdiagnosed due to its unique symptoms and potential systemic effects. This case highlights the diagnostic challenges, even for specialists.

More Related Videos

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Related Experiment Videos

Last Updated: Jun 15, 2026

Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats
13:26

Induction and Monitoring of Active Delayed Type Hypersensitivity (DTH) in Rats

Published on: July 19, 2007

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Delayed Pressure Urticaria (DPU) is an uncommon physical urticaria characterized by delayed wheal and flare reactions to pressure.
  • DPU can present with systemic symptoms, complicating diagnosis and differentiating it from classical urticaria.
  • Underdiagnosis is frequent, even among specialists, due to its atypical presentation.

Observation:

  • A case report details a patient presenting with typical pressure-induced lesions consistent with DPU.
  • The patient also exhibited fever and leukocytosis, symptoms not typically associated with uncomplicated DPU.
  • These systemic signs prompted hospital admission for infectious disease investigation.

Findings:

  • The patient's presentation mimicked an infectious process due to fever and leukocytosis.
  • Diagnostic delay occurred because the characteristic delayed pressure urticaria symptoms were overshadowed by systemic signs.
  • This case underscores the importance of considering DPU even in the presence of seemingly unrelated systemic manifestations.

Implications:

  • Highlights the diagnostic complexity of Delayed Pressure Urticaria, particularly when systemic symptoms are present.
  • Emphasizes the need for heightened clinical suspicion for DPU in patients with unexplained fever and leukocytosis.
  • Suggests that a broader differential diagnosis, including rare conditions like DPU, is crucial for accurate patient management.